[vc_row][vc_column][vc_column_text]
High Fives for Sharing!
We are using Myositis Mask Memes and images to share a short message as it relates to the MSU theme, High Fives from the Heart: #MyositisLIFE in a Pandemic World. Share yours today![/vc_column_text][vc_masonry_grid post_type=”post” max_items=”-1″ gap=”5″ item=”masonryGrid_OverlayWithRotation” grid_id=”vc_gid:1589719191291-8f01a8e7-3426-2″ taxonomies=”169″][/vc_column][/vc_row][vc_row][vc_column][vc_separator color=”blue” style=”dotted”][/vc_column][/vc_row][vc_row][vc_column width=”1/4″][vc_single_image image=”3496″ img_size=”medium” onclick=”custom_link” img_link_target=”_blank” link=”https://www.corbuspharma.com/for-patients/clinical-trials/phase-3-determine-study-in-dermatomyositis/?utm_source=sponsors-2020&utm_medium=display&utm_campaign=myolifemask”][/vc_column][vc_column width=”3/4″][vc_column_text]
Sponsored by Corbus Pharmaceuticals
Corbus Pharmaceuticals is focused on the development and commercialization of novel therapeutics by harnessing its platform of endocannabinoid system-targeting drug candidates. The company’s lead product candidate, lenabasum, is designed to resolve inflammation, limit fibrosis and support tissue repair. Lenabasum is not approved for the treatment of dermatomyositis.
Learn more about the clinical trial for dermatomyositis[/vc_column_text][/vc_column][/vc_row]